CO6150169A2 - Benzoxazinonas sustituidas enantiomericamente puras y procedimientos para su preparacion - Google Patents
Benzoxazinonas sustituidas enantiomericamente puras y procedimientos para su preparacionInfo
- Publication number
- CO6150169A2 CO6150169A2 CO09016428A CO09016428A CO6150169A2 CO 6150169 A2 CO6150169 A2 CO 6150169A2 CO 09016428 A CO09016428 A CO 09016428A CO 09016428 A CO09016428 A CO 09016428A CO 6150169 A2 CO6150169 A2 CO 6150169A2
- Authority
- CO
- Colombia
- Prior art keywords
- tautomers
- benzoate
- negatively charged
- enantiomerically pure
- charged anion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
1.- Compuestos enantioméricamente puros de la fórmula 1en dondeR1 y R2 significan, de modo independiente entre sí, H, o halógeno o alquilo C1-4 o juntos significan alquileno C1-6; y R3 significa H, halógeno, OH, alquilo C1-4 u O-alquilo C1-4;Ym- significa un anión cargado negativamente m veces, con preferencia un anión cargado negativamente m veces seleccionado del grupo compuesto por cloruro, bromuro, yoduro, sulfato, fosfato, metansulfonato, nitrato, maleinato, acetato, benzoato] citrato, salicilato, trifluoroacetato, fumarato, tartrato, oxalato, succinato, etandisulfonato, propandisulfonato, benzoato y ptoluensulfonato, m significa 1 ó 2, eventualmente en forma de sus tautómeros, mezclas de los tautómeros, hidratos o solvatos. 2.- Compuestos enantioméricamente puros de la fórmula 1 de acuerdo con la reivindicación 1, en donde R1 y R2 iguales o diferentes, significan hidrógeno, flúor, cloro, metilo, etilo, propilo, butilo o conjuntamente -CH2-CH2-, -CH2-CH2-CH2-, -CH2-CH2-CH2-CH2- o -CH2-CH2-CH2-CH2-CH2-; R3 significa hidrógeno, flúor, cloro, OH, metilo, etilo, metoxi o etoxi; Ym- significa un anión cargado negativamente m veces, con preferencia un anión cargado negativamente m veces seleccionado del grupo compuesto por cloruro, bromuro, yoduro, sulfato, fosfato, metansulfonato, nitrato, maleinato, acetato, benzoato, citrato, salicilato, trifluoroacetato, fumarato, tartrato, oxalato, succinato, etandisulfonato, benzoato y p-toluensulfonato, m significa 1 ó 2, eventualmente en forma de sus tautómeros, mezclas de los tautómeros, hidratos o solvatos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06119273 | 2006-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6150169A2 true CO6150169A2 (es) | 2010-04-20 |
Family
ID=38698758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09016428A CO6150169A2 (es) | 2006-08-22 | 2009-02-19 | Benzoxazinonas sustituidas enantiomericamente puras y procedimientos para su preparacion |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7709474B2 (es) |
| EP (1) | EP2057134A1 (es) |
| JP (1) | JP2010501522A (es) |
| KR (1) | KR20090043586A (es) |
| CN (1) | CN101506182A (es) |
| AR (1) | AR062476A1 (es) |
| AU (1) | AU2007287537A1 (es) |
| BR (1) | BRPI0715690A2 (es) |
| CA (1) | CA2661143A1 (es) |
| CO (1) | CO6150169A2 (es) |
| EA (1) | EA200900268A1 (es) |
| EC (1) | ECSP099082A (es) |
| IL (1) | IL197124A0 (es) |
| MX (1) | MX2009001515A (es) |
| NO (1) | NO20090101L (es) |
| NZ (1) | NZ575567A (es) |
| PE (1) | PE20080610A1 (es) |
| TW (1) | TW200817347A (es) |
| UA (1) | UA96951C2 (es) |
| UY (1) | UY30550A1 (es) |
| WO (1) | WO2008023004A1 (es) |
| ZA (1) | ZA200810829B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010501520A (ja) * | 2006-08-22 | 2010-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 光学異性的に純粋なベータ作動薬を含む吸入用粉末製剤 |
| PE20080425A1 (es) * | 2006-08-22 | 2008-06-16 | Boehringer Ingelheim Int | Formulacion aerosol para la inhalacion de beta-agonistas |
| JP2010529155A (ja) | 2007-06-13 | 2010-08-26 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 出血性疾患の治療及び予防的処置における血管外投与のためのｖｗｆ安定化ｆｖｉｉｉ製剤及びｆｖｉｉｉなしのｖｗｆ製剤の使用 |
| EP2093219A1 (de) | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel |
| ES2657291T3 (es) | 2013-04-22 | 2018-03-02 | Csl Ltd. | Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3026534A1 (de) * | 1980-07-12 | 1982-03-18 | C.H. Boehringer Sohn, 6507 Ingelheim | 3,1-benzoxazin-2-one, ihre herstellung und verwendung |
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
| DE3609152A1 (de) * | 1986-03-19 | 1987-09-24 | Bayer Ag | Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| IL107120A (en) | 1992-09-29 | 1997-09-30 | Boehringer Ingelheim Int | Atomising nozzle and filter and spray generating device |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| US5495054A (en) | 1994-05-31 | 1996-02-27 | Sepracor, Inc. | Tetrahydroindeno[1,2-D][1,3,2]oxazaboroles and their use as enantioselective catalysts |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19536903C2 (de) | 1995-10-04 | 1998-09-10 | Boehringer Ingelheim Int | Vorrichtung zum Haltern eines fluidischen Bauteils |
| DE19545226C1 (de) | 1995-12-05 | 1997-06-19 | Boehringer Ingelheim Int | Sperrspannwerk für einen federbetätigten Abtrieb |
| DE19742439C1 (de) | 1997-09-26 | 1998-10-22 | Boehringer Ingelheim Int | Mikrostrukturiertes Filter |
| BR0114584A (pt) | 2000-10-12 | 2003-08-26 | Boehringer Ingelheim Pharma | Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento |
| DE10050995A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| HUP0400333A3 (en) | 2001-06-22 | 2012-10-29 | Boehringer Ingelheim Pharma | Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition |
| DE10203753A1 (de) | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE10203741A1 (de) | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE10203749A1 (de) | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| JP4516064B2 (ja) | 2003-04-04 | 2010-08-04 | ノバルティス アーゲー | 気道疾患の処置のためのキノリン−２−オン誘導体 |
| DE102004003428A1 (de) * | 2004-01-23 | 2005-08-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel |
| DE102004024454A1 (de) | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| PE20080425A1 (es) * | 2006-08-22 | 2008-06-16 | Boehringer Ingelheim Int | Formulacion aerosol para la inhalacion de beta-agonistas |
| UY30552A1 (es) * | 2006-08-22 | 2008-03-31 | Boehringer Ingelheim Int | Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones |
-
2007
- 2007-08-20 PE PE2007001125A patent/PE20080610A1/es not_active Application Discontinuation
- 2007-08-20 UY UY30550A patent/UY30550A1/es not_active Application Discontinuation
- 2007-08-21 TW TW096130900A patent/TW200817347A/zh unknown
- 2007-08-21 NZ NZ575567A patent/NZ575567A/en not_active IP Right Cessation
- 2007-08-21 CN CNA2007800311865A patent/CN101506182A/zh active Pending
- 2007-08-21 AU AU2007287537A patent/AU2007287537A1/en not_active Abandoned
- 2007-08-21 WO PCT/EP2007/058654 patent/WO2008023004A1/de active Application Filing
- 2007-08-21 UA UAA200902356A patent/UA96951C2/ru unknown
- 2007-08-21 EP EP07802746A patent/EP2057134A1/de not_active Withdrawn
- 2007-08-21 US US11/842,485 patent/US7709474B2/en active Active
- 2007-08-21 CA CA002661143A patent/CA2661143A1/en not_active Abandoned
- 2007-08-21 JP JP2009525052A patent/JP2010501522A/ja active Pending
- 2007-08-21 EA EA200900268A patent/EA200900268A1/ru unknown
- 2007-08-21 MX MX2009001515A patent/MX2009001515A/es active IP Right Grant
- 2007-08-21 BR BRPI0715690-1A2A patent/BRPI0715690A2/pt not_active IP Right Cessation
- 2007-08-21 KR KR1020097005850A patent/KR20090043586A/ko not_active Application Discontinuation
- 2007-08-22 AR ARP070103721A patent/AR062476A1/es not_active Application Discontinuation
-
2008
- 2008-12-23 ZA ZA200810829A patent/ZA200810829B/xx unknown
-
2009
- 2009-01-08 NO NO20090101A patent/NO20090101L/no not_active Application Discontinuation
- 2009-01-20 EC EC2009009082A patent/ECSP099082A/es unknown
- 2009-02-19 CO CO09016428A patent/CO6150169A2/es unknown
- 2009-02-19 IL IL197124A patent/IL197124A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101506182A (zh) | 2009-08-12 |
| CA2661143A1 (en) | 2008-02-28 |
| US20080070909A1 (en) | 2008-03-20 |
| WO2008023004A1 (de) | 2008-02-28 |
| NZ575567A (en) | 2011-12-22 |
| JP2010501522A (ja) | 2010-01-21 |
| NO20090101L (no) | 2009-01-29 |
| AU2007287537A1 (en) | 2008-02-28 |
| TW200817347A (en) | 2008-04-16 |
| MX2009001515A (es) | 2009-02-18 |
| ZA200810829B (en) | 2009-11-25 |
| IL197124A0 (en) | 2009-11-18 |
| UA96951C2 (ru) | 2011-12-26 |
| UY30550A1 (es) | 2008-03-31 |
| KR20090043586A (ko) | 2009-05-06 |
| EA200900268A1 (ru) | 2009-08-28 |
| US7709474B2 (en) | 2010-05-04 |
| AR062476A1 (es) | 2008-11-12 |
| PE20080610A1 (es) | 2008-07-15 |
| EP2057134A1 (de) | 2009-05-13 |
| WO2008023004A8 (de) | 2008-05-22 |
| ECSP099082A (es) | 2009-02-27 |
| BRPI0715690A2 (pt) | 2013-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6150169A2 (es) | Benzoxazinonas sustituidas enantiomericamente puras y procedimientos para su preparacion | |
| AR058082A1 (es) | Formulacion en aerosol para la inhalacion de beta- agonistas | |
| JP2017088633A5 (es) | ||
| PE20191744A1 (es) | Derivados de tirosinamida como inhibidores de rho-quinasa | |
| ES2579175T3 (es) | Proceso para la producción de intermediarios de estetrol | |
| RU2006144123A (ru) | Новые энантиомерночистые в-агонисты, способ их получения и их применение в качестве лекарственных средств | |
| IL263543A (en) | Methods and devices for synthesizing imaging agents, and their intermediates | |
| AR085683A1 (es) | Compuestos de piridona y aza-piridona y metodos de uso | |
| AR041941A1 (es) | Derivado de 1-aminociclohexano sustituidos en la posicion 4 utilizado como receptor orl1 | |
| UY29047A1 (es) | Derivados de sulfonamidas, su preparación y su aplicación en terapéutica | |
| IN266790B (es) | ||
| BR112014027190A2 (pt) | pirrolobenzodiazepinas | |
| NZ608584A (en) | Substituted n-(2-arylamino)aryl sulfonamide-containing combinations | |
| PH12016500234A1 (en) | Tricyclic benzoxaborole compounds and uses thereof | |
| CY1123779T1 (el) | Κολονοσκοπηση-προετοιμασια | |
| MY157676A (en) | Diphenyl-pyrazolopyridine derivatives,preparation thereof, and use thereof as nuclear receptor not modulators | |
| ECSP067111A (es) | Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica | |
| AR066903A1 (es) | Composiciones acondicionadoras del cabello | |
| CO6341634A2 (es) | Nuevos derivados de imidazo(1,2-a)pirimidina, su procesamiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
| NI200900183A (es) | Compuestos de pirido [2,3-d] pirimidina - 7 - ona como inhibidores de pi3k - alfa para el tratamiento del cáncer. | |
| AR049096A1 (es) | Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas | |
| PE20181331A1 (es) | NUEVOS DERIVADOS DE IMIDAZO [4,5-b] PIRIDINA UN PROCESO PARA SU PREPRACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
| CL2021000904A1 (es) | Método para convertir las formas e, f y g cristalinas de la sal de bis-bromuro de hidrógeno de (s)-n-((5-(etilsulfonil)piridin-2-il)metil)-7-isopropil-6-((trans-4-(trifluorometil) ciclohexil) metil)-6,7-dihidro-5h-pirrolo[3,4-b]piridin-3-carboxamida en la forma d cristalina de la sal de bis-bromuro de hidrógeno. solicitud divisional de la solicitud 190-2020 | |
| NZ601284A (en) | Sulfone compounds as 5-ht6 receptor ligands | |
| AR059126A1 (es) | Uso de sales de tiotropio en el tratamiento del asma persistente moderada |